Support for People Suffering from Anxiety and Stress

Summary

To help people manage their anxiety and stress better, we created a short, new intervention, which we call the “Unified Protocol” or “UP” that will be delivered in an online or in-person group format over the course of 5 weeks. You may be experiencing a lot of anxiety and stress right now. You may be worried about your own health or the health of your friends and family. You are not alone. The future is uncertain, and many people find this lack of certainty distressing. One key skill that the UP teaches is how to cope with the anxiety and distress caused by not knowing how the future will unfold.

If you are interested in more information about the study or would like to participate in a group intervention to help you cope with stress, please email us at up@ucalgary.ca. If you would prefer to talk with us via phone, please email us your phone number and we will call you back.

Eligibility

Currently recruiting participants: Yes

Eligible gender: Male, Female, Transgender, Other

Eligible ages: 12 to 100

Accepts healthy participants: Yes

Inclusion criteria:

To participate you need to be
1) A person aged 12-24 or a caregiver of a child or youth between the age of 0-24.
2) Be connected to a family physician, primary health care network or student wellness centre.
3) Have reliable internet access and be able to access Zoom using a camera and a microphone (on a tablet, phone or computer) if participating online, or be able to participate in-person for certain locations.

Exclusion criteria:

1. People who are not proficient in English.
2. People who have had a recent suicide attempt or require hospitalization for psychiatric services.
3. People who are not connected to a family physician, primary health network or a student wellness centre.

Participate

Fill out the following form if you want to participate in this research

Method of contact

Additional information

Contact information

Email: up@ucalgary.ca

Principal investigator:

Gina Dimitropoulos

Clinical trial:

No

REB-ID:

REB20-0528